EcoDrugPlus

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSBMSG00010008810
Gene Symbol: APEX1
1 Cross references
214 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSBMSG00010020498
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSBMSG00010022339
Gene Symbol: ALOX5
1 Cross references
222 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSBMSG00010015580
Gene Symbol: ALOX5AP
1 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSBMSG00010014162
Gene Symbol: AVPR1A
1 Cross references
268 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSBMSG00010002218
Gene Symbol: AVPR1B
1 Cross references
135 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSBMSG00010018770
Gene Symbol: AVPR2
1 Cross references
251 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSBMSG00010006134
Gene Symbol: AHR
1 Cross references
155 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSBMSG00010017273
Gene Symbol: AURKA
1 Cross references
233 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSBMSG00010018326
Gene Symbol: AURKC
1 Cross references
99 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSBMSG00010013422
Gene Symbol: BACE1
1 Cross references
220 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSBMSG00010002634
Gene Symbol: BDKRB1
1 Cross references
149 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).